NeoGenix Biosciences
Innovation is the Future of IVF.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| investor | €0.0 | round | |
* | N/A | Seed | |
| Total Funding | 000k | ||
NeoGenix Biosciences is a pioneering company in the fertility treatment sector, established in 2019 by a team of fertility experts, researchers, and biomedical engineers. The company focuses on developing innovative and insightful technologies aimed at modernising fertility treatments globally. NeoGenix Biosciences serves IVF technicians and embryologists by providing advanced solutions for sperm selection, gamete handling, AI-based gamete detection, and fertilisation platforms. Operating in the fertility treatment market, the company employs a user-centred design approach to ensure their technologies are translatable and effective. NeoGenix Biosciences generates revenue through the sale of its specialised fertility treatment technologies and platforms. The business model revolves around continuous innovation and close collaboration with end-users to meet their expectations and needs.
Keywords: fertility, IVF, sperm selection, gamete handling, AI detection, fertilisation, biomedical engineering, user-centred design, innovative technology, global market.